Dehydroepiandrosterone sulfate and anovulation increase serum inhibin and affect follicular function during administration of gonadotropins

Ray V. Haning, Jenny J. Hua, Richard J. Hackett, Carol A. Wheeler, Gary N. Frishman, David Seifer, Cecilia A. Dahl, Henry G. Burger

Research output: Contribution to journalArticle

Abstract

To test the hypothesis that testosterone (T) derived from circulating dehydroepiandrosterone sulfate (DS) or produced in excess within the anovulatory ovary is a follicular regulator capable of stimulating inhibin secretion, DS and inhibin were determined by RIA in residual serum samples from in vitro fertilization cycles and analyzed along with other parameters using analysis of variance and stepwise multiple linear regression after log transformation of the RIA data. It was predicted that the serum concentration of inhibin would be higher in women with anovulation than in normal subjects and that the serum inhibin concentration would have a positive regression coefficient on the serum DS concentration. The serum concentrations of inhibin (P <0.01) and estradiol (P <0.001) on the day of hCG treatment were higher in women with anovulation than in normal subjects, as was the number of oocytes retrieved (P <0.001). The FSH and LH doses (both P <0.005) and age (P <0.001) were significantly lower, and the average duration of gonadotropin therapy was 1 day shorter (P <0.001) in anovulatory patients. There was no significant difference in serum DS (P > 0.2). Regression analysis showed that serum inhibin was positively related to the number of oocytes (P <0.001) and serum DS (P = 0.05), with an increase in anovulatory subjects (P <0.025). The duration of treatment with gonadotropins was related positively to the patient's age (P <0.001) and negatively to serum DS (P <0.025), with a decrease in anovulatory subjects (P <0.025). The number of oocytes obtained was negatively related to age (P <0.001) and positively to serum DS (P <0.005). These data are consistent with a stimulatory effect of follicular T derived from either circulating DS or the anovulatory ovary, which affects the secretion of inhibin, the duration of gonadotropin treatment, and the number of oocytes retrieved.

Original languageEnglish (US)
Pages (from-to)145-149
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume78
Issue number1
DOIs
StatePublished - Jan 1994
Externally publishedYes

Fingerprint

Anovulation
Dehydroepiandrosterone Sulfate
Inhibins
Gonadotropins
Serum
Oocytes
Ovary
Analysis of variance (ANOVA)
Linear regression
Regression analysis
Testosterone
Fertilization in Vitro
Linear Models
Analysis of Variance
Regression Analysis

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Dehydroepiandrosterone sulfate and anovulation increase serum inhibin and affect follicular function during administration of gonadotropins. / Haning, Ray V.; Hua, Jenny J.; Hackett, Richard J.; Wheeler, Carol A.; Frishman, Gary N.; Seifer, David; Dahl, Cecilia A.; Burger, Henry G.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 78, No. 1, 01.1994, p. 145-149.

Research output: Contribution to journalArticle

Haning, Ray V. ; Hua, Jenny J. ; Hackett, Richard J. ; Wheeler, Carol A. ; Frishman, Gary N. ; Seifer, David ; Dahl, Cecilia A. ; Burger, Henry G. / Dehydroepiandrosterone sulfate and anovulation increase serum inhibin and affect follicular function during administration of gonadotropins. In: Journal of Clinical Endocrinology and Metabolism. 1994 ; Vol. 78, No. 1. pp. 145-149.
@article{b8efed5ad73040ad84deb68e6e05ce94,
title = "Dehydroepiandrosterone sulfate and anovulation increase serum inhibin and affect follicular function during administration of gonadotropins",
abstract = "To test the hypothesis that testosterone (T) derived from circulating dehydroepiandrosterone sulfate (DS) or produced in excess within the anovulatory ovary is a follicular regulator capable of stimulating inhibin secretion, DS and inhibin were determined by RIA in residual serum samples from in vitro fertilization cycles and analyzed along with other parameters using analysis of variance and stepwise multiple linear regression after log transformation of the RIA data. It was predicted that the serum concentration of inhibin would be higher in women with anovulation than in normal subjects and that the serum inhibin concentration would have a positive regression coefficient on the serum DS concentration. The serum concentrations of inhibin (P <0.01) and estradiol (P <0.001) on the day of hCG treatment were higher in women with anovulation than in normal subjects, as was the number of oocytes retrieved (P <0.001). The FSH and LH doses (both P <0.005) and age (P <0.001) were significantly lower, and the average duration of gonadotropin therapy was 1 day shorter (P <0.001) in anovulatory patients. There was no significant difference in serum DS (P > 0.2). Regression analysis showed that serum inhibin was positively related to the number of oocytes (P <0.001) and serum DS (P = 0.05), with an increase in anovulatory subjects (P <0.025). The duration of treatment with gonadotropins was related positively to the patient's age (P <0.001) and negatively to serum DS (P <0.025), with a decrease in anovulatory subjects (P <0.025). The number of oocytes obtained was negatively related to age (P <0.001) and positively to serum DS (P <0.005). These data are consistent with a stimulatory effect of follicular T derived from either circulating DS or the anovulatory ovary, which affects the secretion of inhibin, the duration of gonadotropin treatment, and the number of oocytes retrieved.",
author = "Haning, {Ray V.} and Hua, {Jenny J.} and Hackett, {Richard J.} and Wheeler, {Carol A.} and Frishman, {Gary N.} and David Seifer and Dahl, {Cecilia A.} and Burger, {Henry G.}",
year = "1994",
month = "1",
doi = "10.1210/jc.78.1.145",
language = "English (US)",
volume = "78",
pages = "145--149",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Dehydroepiandrosterone sulfate and anovulation increase serum inhibin and affect follicular function during administration of gonadotropins

AU - Haning, Ray V.

AU - Hua, Jenny J.

AU - Hackett, Richard J.

AU - Wheeler, Carol A.

AU - Frishman, Gary N.

AU - Seifer, David

AU - Dahl, Cecilia A.

AU - Burger, Henry G.

PY - 1994/1

Y1 - 1994/1

N2 - To test the hypothesis that testosterone (T) derived from circulating dehydroepiandrosterone sulfate (DS) or produced in excess within the anovulatory ovary is a follicular regulator capable of stimulating inhibin secretion, DS and inhibin were determined by RIA in residual serum samples from in vitro fertilization cycles and analyzed along with other parameters using analysis of variance and stepwise multiple linear regression after log transformation of the RIA data. It was predicted that the serum concentration of inhibin would be higher in women with anovulation than in normal subjects and that the serum inhibin concentration would have a positive regression coefficient on the serum DS concentration. The serum concentrations of inhibin (P <0.01) and estradiol (P <0.001) on the day of hCG treatment were higher in women with anovulation than in normal subjects, as was the number of oocytes retrieved (P <0.001). The FSH and LH doses (both P <0.005) and age (P <0.001) were significantly lower, and the average duration of gonadotropin therapy was 1 day shorter (P <0.001) in anovulatory patients. There was no significant difference in serum DS (P > 0.2). Regression analysis showed that serum inhibin was positively related to the number of oocytes (P <0.001) and serum DS (P = 0.05), with an increase in anovulatory subjects (P <0.025). The duration of treatment with gonadotropins was related positively to the patient's age (P <0.001) and negatively to serum DS (P <0.025), with a decrease in anovulatory subjects (P <0.025). The number of oocytes obtained was negatively related to age (P <0.001) and positively to serum DS (P <0.005). These data are consistent with a stimulatory effect of follicular T derived from either circulating DS or the anovulatory ovary, which affects the secretion of inhibin, the duration of gonadotropin treatment, and the number of oocytes retrieved.

AB - To test the hypothesis that testosterone (T) derived from circulating dehydroepiandrosterone sulfate (DS) or produced in excess within the anovulatory ovary is a follicular regulator capable of stimulating inhibin secretion, DS and inhibin were determined by RIA in residual serum samples from in vitro fertilization cycles and analyzed along with other parameters using analysis of variance and stepwise multiple linear regression after log transformation of the RIA data. It was predicted that the serum concentration of inhibin would be higher in women with anovulation than in normal subjects and that the serum inhibin concentration would have a positive regression coefficient on the serum DS concentration. The serum concentrations of inhibin (P <0.01) and estradiol (P <0.001) on the day of hCG treatment were higher in women with anovulation than in normal subjects, as was the number of oocytes retrieved (P <0.001). The FSH and LH doses (both P <0.005) and age (P <0.001) were significantly lower, and the average duration of gonadotropin therapy was 1 day shorter (P <0.001) in anovulatory patients. There was no significant difference in serum DS (P > 0.2). Regression analysis showed that serum inhibin was positively related to the number of oocytes (P <0.001) and serum DS (P = 0.05), with an increase in anovulatory subjects (P <0.025). The duration of treatment with gonadotropins was related positively to the patient's age (P <0.001) and negatively to serum DS (P <0.025), with a decrease in anovulatory subjects (P <0.025). The number of oocytes obtained was negatively related to age (P <0.001) and positively to serum DS (P <0.005). These data are consistent with a stimulatory effect of follicular T derived from either circulating DS or the anovulatory ovary, which affects the secretion of inhibin, the duration of gonadotropin treatment, and the number of oocytes retrieved.

UR - http://www.scopus.com/inward/record.url?scp=0028158616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028158616&partnerID=8YFLogxK

U2 - 10.1210/jc.78.1.145

DO - 10.1210/jc.78.1.145

M3 - Article

VL - 78

SP - 145

EP - 149

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 1

ER -